• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.

作者信息

Eo Wan Kyu, Kim Se Hyun, Cheon Seong Ha, Lee Sang Hun, Jeong Jong Soo, Kim Yang Soo, Chang Hee Kyung, Suh Kee Suck, Kim Heung Yeol

出版信息

Ann Hematol. 2010 Apr;89(4):421-2. doi: 10.1007/s00277-009-0810-y. Epub 2009 Aug 20.

DOI:10.1007/s00277-009-0810-y
PMID:19693501
Abstract
摘要

相似文献

1
Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
Ann Hematol. 2010 Apr;89(4):421-2. doi: 10.1007/s00277-009-0810-y. Epub 2009 Aug 20.
2
Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.沙利度胺和地塞米松治疗新诊断多发性骨髓瘤后的肿瘤溶解综合征
Exp Hematol. 2006 Dec;34(12):1616. doi: 10.1016/j.exphem.2006.07.010.
3
Lenalidomide and its role in the management of multiple myeloma.来那度胺及其在多发性骨髓瘤治疗中的作用。
Expert Rev Anticancer Ther. 2008 Jun;8(6):865-74. doi: 10.1586/14737140.8.6.865.
4
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma.沙利度胺治疗骨髓瘤导致危及生命的中毒性表皮坏死松解症。
N Engl J Med. 2000 Sep 28;343(13):972-3. doi: 10.1056/NEJM200009283431315.
5
The role of thalidomide in multiple myeloma.沙利度胺在多发性骨髓瘤中的作用。
Clin Lymphoma Myeloma. 2006 Jul;7(1):26-9. doi: 10.3816/CLM.2006.n.035.
6
Toxic epidermal necrolysis induced by thalidomide and dexamethasone treatment for multiple myeloma.
Int J Dermatol. 2017 Feb;56(2):e35-e37. doi: 10.1111/ijd.13431. Epub 2016 Nov 2.
7
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.在肿瘤溶解综合征发生后，采用硼替佐米/沙利度胺/地塞米松联合疗法使多发性骨髓瘤迅速完全缓解。
Cancer Chemother Pharmacol. 2008 Jun;62(1):181-2. doi: 10.1007/s00280-007-0574-9. Epub 2007 Aug 31.
8
Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.来那度胺、阿霉素和地塞米松联合疗法（RAD）治疗复发/难治性多发性骨髓瘤（MM）的安全性和有效性：单中心经验
Ann Hematol. 2011 Jan;90(1):115-6. doi: 10.1007/s00277-010-0967-4. Epub 2010 Apr 27.
9
Thalidomide and dexamethasone: therapy for multiple myeloma.沙利度胺与地塞米松：用于治疗多发性骨髓瘤
Expert Rev Anticancer Ther. 2005 Oct;5(5):759-66. doi: 10.1586/14737140.5.5.759.
10
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.硼替佐米联合地塞米松及后续沙利度胺治疗新诊断的多发性骨髓瘤：中国经验
Leuk Res. 2009 Dec;33(12):1615-8. doi: 10.1016/j.leukres.2009.04.006.

引用本文的文献

1
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
2
Life-threatening dermatologic adverse events in oncology.肿瘤学中危及生命的皮肤不良反应。
Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032.
3
Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database.
沙利度胺与来那度胺严重不良反应比较：法国药物警戒数据库分析。
Med Oncol. 2013 Dec;30(4):733. doi: 10.1007/s12032-013-0733-2. Epub 2013 Sep 28.
4
Therapeutic effects of thalidomide in hematologic disorders: a review.沙利度胺在血液系统疾病中的治疗作用：综述。
Front Med. 2013 Sep;7(3):290-300. doi: 10.1007/s11684-013-0277-z. Epub 2013 Jul 15.